Introduction
The status of axillary lymph nodes is the most important factor in predicting long-term survival and subsequently affects the decision for adjuvant therapy in some cases of breast cancer [1] . However, the aim and extent of axillary lymph node dissection (ALND) Alhussini/Awad/Ashour/Abdelateef/Fayed Breast Care 2016;11:265-268 266
All patients included in the study had no suspicious axillary lymph nodes both by clinical examination and ultrasonography. SLN detection was done by injecting 1.8 ml of MB dye in the sub-areolar region just after induction of anesthesia and tapping massage was done for 8-10 min. The axilla was then explored via a small incision at the lowest hairline. SLNs were identified by being blue stained or having blue lymphatic entering it or both together. Formal level I and level II axillary dissection was done in order to assess that the harvested SLN truly represents the axillary lymph node status.
Results
This study included 144 patients with 2 of them suffering of bilateral disease. Hence, 146 procedures were done. The age ranged from 25 to 84 years with a mean of 53.73 ± 12.15 years. Premenopausal cases constituted 44.4% (64 cases) of the whole studied group.
The axillary lymph node status, after standard levels I and II dissection was found negative in 100 (68.5%) patients and positive in the remaining 46 patients (31.5%). The number of nodes dissected ranged from 8 to 18 nodes with a mean of 11.81 ± 2.40 (table 1).
The procedure failed to identify the SLN 10 times and succeeded 136 times ( fig. 1, 2) . Thus, the identification rate was 93.15%. The number of SLN identified ranged from 1 to 8 nodes with a mean of 1.75 ± 1.17. The SLN was negative in 84 (61.8%) patients and was affected with metastasis in the other 52 (38.2%) patients.
Of the 10 cases in which the technique failed to identify the SLN, 8 cases were found to have axillary lymph node involvement with metastasis while the remaining 2 were free.
To correlate the state of the SLN with the state of the axilla, we excluded the 10 cases in which the technique failed. Thus, in 136 cases of identified SLN, the sentinel and axillary nodes status coincided in 118 patients. Both the SLN and axillary nodes were free of metastases in 82 patients (60.3%; table 2) and both were found involved in 36 patients (26.5%). The SLN was the only site of metastasis encountered with no other positive nodes in 16 patients (11.8%). 2 patients showed a false negative result. In these patients, the axilla was found involved with micrometastases that were not detected intraoperatively by frozen section. In our study, the sensi- tivity of MB dye technique was 96.3%. The false negative rate, which is considered the most important figure in the study, was 3.7%. The negative predictive value was 97.6% and the accuracy was 98.5%. As regards the side effects of MB, 4 patients (2.8%) reported bluish or greenish discoloration of urine in the first 24 h following surgery. 1 patient with bilateral breast cancer developed superficial gangrene involving both areolas. This patient was suffering from chronic dryness of the skin and may be considered a wrongly selected case. She was managed by debridement and frequent dressing but was lost in the follow-up period. We did not report any case with localized allergy or systemic anaphylaxis to MB.
Discussion
Combining radioactive colloid with blue dye injection is the best way to assess SLNB in breast cancer [20, 21] .
Many institutions and hospitals in developing countries -including ours -still routinely do complete ALND. This is partly attributed to the belief that axillary dissection, although falsely, gives the impression of security and partly to the lack of access or finance to provide isotopes and gamma probes. Therefore, we aimed at evaluating the accuracy of MB alone in assessing the SLN and axillary status.
The identification rate of the SLN in our study was 93.15%. Kern [22] reported an identification rate of 97.5% and in the work by Golshan and Nakhlis [19] the identification rate was 96.5%. Both Kern [22] and Golshan and Nakhlis [19] used the sub-areolar isolated blue dye technique with the difference that Kern [22] used patent blue dye while Golshan and Nakhlis [19] used MB dye. Mokbel and Mostafa [23] also used the sub-areolar injection of MB dye in a study including 35 patients and the identification rate was 97% (34 patients). He reported a failure in a 77-year-old woman who had metastasis in 5 out of 13 lymph nodes dissected. Moreover, he reported no side effects of MB apart from temporary tattooing of the skin.
Varghese et al. [18] used the MB peritumorally for the identification of SLN. The identification rate was 96.5%. They attributed the rate of identification to the number of procedures performed.
Thus, we state that the built up experience of the surgeon plays a major role both in the time and accuracy of identification.
The number of SLN identified ranged from 1 to 8 nodes with mean of 1.75 ± 1.17. Radovanovic et al. [24] reported similar results in both groups of their study as the mean number of SLN was 1.7 and 1.6. This is consistent with the results of Mokbel and Mostafa [23] and Anan et al. [25] who mentioned that the mean number of SLN identified was 2 and 1.6, respectively. The latter authors interestingly studied double mapping with sub-areolar blue dye and peritumoral green dye.
Giuliano et al. [26] showed a false negative rate of 12%. He stated that misidentification of blue stained fat as a SLN was an important cause of false negative rate but introduction of frozen section solved the problem and the false negative rate became 0% in his next series [27] 3 years later.
Kern [22] showed a false negative rate of 0% while Guenther et al. [28] showed a false negative rate of 9.7% and he stated that false negative rate was at early phase of the study due to lack of experience.
Veronesi et al. [9] had a false negative rate of 5%, while Tafra et al. [29] had a 0% false negative rate. This was explained by the usage of combined technique (using blue dye and radioactive colloid technique) for identification of the SLNs, and also the use of immunohistochemical stains in revision of SLN for patients with negative SLNs and positive non-SLN metastasis.
In the current study, the false negative rate was 3.7% which we think is quite acceptable and comparable to the results of other methods.In the present study, we stressed upon the negative state of axillary lymph nodes by clinical examination as well as by imaging procedures. Therefore, the use of MB alone as a sole tracer for SLN detection is a safe, simple, and reliable technique. The built-up experience is essential in overcoming the challenge of finding the target node(s).
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